Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel

Pediatric Infectious Disease Journal

Volumn 24, Issue 5, 2005, Pages 434-437

  Sheffer, Rivka ^a   Segal, Danit ^b   Rahamani, Sarit ^a   Dalal, Ilan ^b   Linhart, Yifat ^a   Stein, Michal ^b   Shohat, Tamar ^c   Somekh, Eli ^b  

^a MINISTRY OF HEALTH   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Effectiveness; Varicella vaccine

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

ARTICLE; CHICKENPOX; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DAY CARE; DISEASE SEVERITY; FEMALE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VACCINATION; VARICELLA ZOSTER VIRUS;

AGE DISTRIBUTION; CASE-CONTROL STUDIES; CHICKENPOX; CHICKENPOX VACCINE; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; ISRAEL; MALE; ODDS RATIO; REFERENCE VALUES; RISK ASSESSMENT; SEX DISTRIBUTION; VACCINATION; VACCINES, ATTENUATED;

EID: 18644376710     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000160947.89942.30     Document Type: Article

References (19)

1. Maharshak N, Somekh E. Hospitalization for varicella in central Israel. Acta Paediatr. 1999;88:1279-1283.
2. Somekh E, Maharashak N, Shapira Y, Greenberg D, Dagan R. Hospitalization for primary varicella zoster virus infection and its complications in patients from Southern Israel. Infection. 2000;28:200-204.
3. Somekh E, Dalal I, Shohat T, Ginsberg GM, Romano O. The burden of uncomplicated cases of chickenpox in Israel. J Infect. 2002;45:54-57.
4. Vazquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med. 2001;344:955-960.
5. Clements DA, Moreira SP, Coplan PM, Bland CL, Walter EB. Postlicensure study of varicella vaccine effectiveness in a day-care setting. Pediatr Infect Dis J. 1999;18:1047-1050.
6. Izureta HS, Strebel PM, Blake PA. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA. 1997; 278:1495-1499.
7. Buchholz U, Moolenaar R, Peterson C, Mascola L. Varicella outbreaks after vaccine licensure: should they make you chicken? Pediatrics. 1999;104:561-563.
8. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med. 2002;347:1909-1915.
9. Passwell JH, Hemo B, Levi Y, Ramon R, Friedman N, Lerner-Geva L. Use of a computerized database to study the effectiveness of an attenuated varicella vaccine. Pediatr Infect Dis J. 2004;23:221-226.
10. Miron D, Kitov R, Hendler A. The incidence and severity of chickenpox among previously varicella vaccinated children during outbreak in day care centers. Paper presented at: 22nd Annual Meeting of the European Society for Paediatric Infectious Diseases; May 26-28, 2004; Tampere, Finland.
11. Kraiouchkine N, Shaw AR, Keller PM, Distefano DJ. Comparison of the complete genome sequences of varicella zoster virus Oka/Merck (Varivax) and Oka/GSK (Varilrix). In: 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17, 2003, Chicago, IL Washington, DC: American Society for Microbiology; Abstract G-1652.
12. Lau YL, Vessey SJ, Chan IS, et al. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and Varilrix in healthy children. Vaccine. 2002;20:2942-2949.
13. Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR. Chickenpox outbreak in a highly vaccinated school population. Pediatrics. 2004;113:455-459.
14. Lee BR, Feaver SL, Miller CA, Hedberg CW, Ehresmann KR. An elementary school outbreak of varicella attributed to vaccine failure: policy implications. J Infect Dis. 2004;190:477-483.
15. Vazquez M, LaRussa PS, Gershon AA, et al. Effectiveness over time of varicella vaccine. JAMA. 2004;291:851-855.
16. Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23:132-137.
17. Galil K, Fair E, Mountcastle N, Britz P, Seward J. Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis. 2002;186:102-105.
18. Verstraeten T, Jumaan AO, Mullooly JP, et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics. 2003;112:e98-e103.
19. Clements DA, Zaref JI, Bland CL, Walter EB, Coplan PM. Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina. Arch Pediatr Adolesc Med. 2001;155:455-461.